Brokerages Set Sotera Health (NASDAQ:SHC) Target Price at $16.08

Shares of Sotera Health (NASDAQ:SHC) have been given an average recommendation of “Moderate Buy” by the six brokerages that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $16.08.

Several equities research analysts have commented on SHC shares. Citigroup boosted their price objective on Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, November 6th. Barclays cut their price objective on Sotera Health from $18.00 to $17.00 and set an “overweight” rating for the company in a research note on Tuesday, February 18th. The Goldman Sachs Group started coverage on Sotera Health in a research note on Friday, December 6th. They set a “neutral” rating and a $14.00 price objective for the company. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a research note on Thursday, November 21st.

Sotera Health Stock Performance

NASDAQ SHC opened at $13.47 on Friday. The stock has a market capitalization of $3.82 billion, a price-to-earnings ratio of 53.88 and a beta of 1.91. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.44. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The stock has a 50-day moving average of $13.46 and a 200 day moving average of $14.55.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Blue Trust Inc. grew its position in Sotera Health by 164.3% in the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after acquiring an additional 1,140 shares during the period. Quarry LP purchased a new position in Sotera Health in the fourth quarter worth approximately $28,000. True Wealth Design LLC purchased a new position in Sotera Health in the third quarter worth approximately $32,000. GAMMA Investing LLC grew its position in Sotera Health by 37.5% in the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after acquiring an additional 1,121 shares during the period. Finally, Tower Research Capital LLC TRC grew its position in Sotera Health by 37.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock worth $82,000 after acquiring an additional 1,640 shares during the period. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.